Jussara Gonçalves Vieira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jussara Gonçalves Vieira has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Luciano Pereira Rodrigues
Institute of Engineering, Science and Technology, Federal University of the Jequitinhonha and Mucuri Valleys, Janaúba, Brazil
4 shared publications - David Nascimento Silva Teixeira
Laboratório Experimental de Imunofarmacologia, Universidade Federal do Triângulo Mineiro, Uberaba 38025-180, Brazil
3 shared publications - Alexandre de Paula Rogério
Institute of Health Sciences, Department of Clinical Medicine, Laboratory of Experimental Immunopharmacology, Federal University of Triangulo Mineiro, Uberaba, MG, Brazil
2 shared publications - Carlos Ueira-Vieira
Institute of Biotechnology Federal University of Uberlândia Uberlândia Minas Gerais Brazil
2 shared publications - Kássia Gonçalves de Castro2 shared publications
- Luiz Ricardo Goulart
Institute of Biotechnology, Federal University of Uberlândia, Uberlândia 38405-320, MG, Brazil
2 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1040
Cryptococcus neoformans GXM mimotopes: Bioactivity and modulation of human inflammatory response and oxidative burst in vitro
- 26 October 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1040
Open AccessCryptococcus neoformans GXM mimotopes: Bioactivity and modulation of human inflammatory response and oxidative burst in vitro
- Open Access
- 28 July 2026
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 32 (5)
Selection and Characterization of Novel Glucuronoxylomannan-Mimetic Peptides for Potential Diagnosis of Cryptococcosis
Cryptococcus neoformans is an encapsulated fungal pathogen characterized by a thick polysaccharide capsule, primarily composed of glucuronoxylomannan (GXM), which represents its major virulence factor and a key target for immunodiagnosis. Mimetic peptides that reproduce GXM epitopes may provide standardized, stable alternatives to native polysaccharide antigens for diagnostic and therapeutic applications. This study aimed to identify and characterize novel GXM-mimetic peptides using phage display technology and evaluate their potential as synthetic reagents for the serological diagnosis of cryptococcosis. Phage display biopanning was performed through three successive cycles using a Ph.D.-7™ combinatorial library against the anti-GXM monoclonal antibody (mAb) 18B7. Selected phage clones were sequenced, and the predominant peptide motif was identified. Based on the consensus sequence, three variants were designed: a linear peptide (LP), a cyclic peptide (CP), and a double-cyclic peptide (DP). Their immunoreactivity and diagnostic performance were evaluated via enzyme-linked immunosorbent assay (ELISA), including dose-response, serum reactivity across clinical cohorts (active cryptococcosis, treated patients, and healthy controls), and competitive inhibition assays against native GXM. Biopanning resulted in significant enrichment, with the peptide PPSLYWL (CryMab 1) emerging as the predominant sequence (54.8% frequency). ELISA demonstrated dose-dependent binding of the synthetic variants to mAb 18B7 and effective discrimination between sera from active cryptococcosis patients and control groups. In competitive ELISA, the LP variant successfully inhibited antibody binding to native GXM by 50.86%, confirming its functional antigenic mimicry. The identified GXM-mimetic peptides, particularly the LP and CP variants, exhibit specific immunoreactivity and diagnostic utility. These findings support their potential as standardized, low-cost alternatives to native fungal antigens in cryptococcosis diagnosis and provide a basis for future peptide-based theranostic strategies.
- 28 July 2026
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 32 (5)
Open AccessSelection and Characterization of Novel Glucuronoxylomannan-Mimetic Peptides for Potential Diagnosis of Cryptococcosis
Cryptococcus neoformans is an encapsulated fungal pathogen characterized by a thick polysaccharide capsule, primarily composed of glucuronoxylomannan (GXM), which represents its major virulence factor and a key target for immunodiagnosis. Mimetic peptides that reproduce GXM epitopes may provide standardized, stable alternatives to native polysaccharide antigens for diagnostic and therapeutic applications. This study aimed to identify and characterize novel GXM-mimetic peptides using phage display technology and evaluate their potential as synthetic reagents for the serological diagnosis of cryptococcosis. Phage display biopanning was performed through three successive cycles using a Ph.D.-7™ combinatorial library against the anti-GXM monoclonal antibody (mAb) 18B7. Selected phage clones were sequenced, and the predominant peptide motif was identified. Based on the consensus sequence, three variants were designed: a linear peptide (LP), a cyclic peptide (CP), and a double-cyclic peptide (DP). Their immunoreactivity and diagnostic performance were evaluated via enzyme-linked immunosorbent assay (ELISA), including dose-response, serum reactivity across clinical cohorts (active cryptococcosis, treated patients, and healthy controls), and competitive inhibition assays against native GXM. Biopanning resulted in significant enrichment, with the peptide PPSLYWL (CryMab 1) emerging as the predominant sequence (54.8% frequency). ELISA demonstrated dose-dependent binding of the synthetic variants to mAb 18B7 and effective discrimination between sera from active cryptococcosis patients and control groups. In competitive ELISA, the LP variant successfully inhibited antibody binding to native GXM by 50.86%, confirming its functional antigenic mimicry. The identified GXM-mimetic peptides, particularly the LP and CP variants, exhibit specific immunoreactivity and diagnostic utility. These findings support their potential as standardized, low-cost alternatives to native fungal antigens in cryptococcosis diagnosis and provide a basis for future peptide-based theranostic strategies.
- Open Access
- 22 May 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 370, 152609
High-performance magnetic sorbent derived from silk floss tree (Ceiba speciosa) resin: A sustainable macromolecular approach for rapid petroleum removal
- 22 May 2026
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 370, 152609
Open AccessHigh-performance magnetic sorbent derived from silk floss tree (Ceiba speciosa) resin: A sustainable macromolecular approach for rapid petroleum removal